WASHINGTON, May 15, 2025 (GLOBE NEWSWIRE) -- Cohen Milstein Sellers & Toll PLLC alerts investors that they have until June 16, 2025 to seek appointment as lead plaintiff in a securities class action lawsuit against Zenas BioPharma, Inc. (NASDAQ: ZBIO). The lawsuit, filed in the U.S. District Court for the District of Massachusetts, concerns alleged material misstatements in the company’s September 2024 IPO offering documents. [Click here for information about joining the class action] If you’d like to discuss this matter or your rights before signing up, please contact Molly J. Bowen, a partner at Cohen Milstein, at (202) 408-4600 or [email protected]. The Allegations The complaint alleges that Zenas BioPharma and several of its IPO underwriters overstated the company’s operational funding window. While public filings suggested the company could operate for 24 months on IPO proceeds and existing cash, Zenas BioPharma disclosed just weeks later in its third-quarter SEC report that its runway was only 12 months. Following this disclosure, the company’s stock fell sharply, closing at $8.72 on April 15, 2025—down nearly 49% from the IPO price. Who Should Consider Seeking Lead Plaintiff Status? Investors who purchased shares pursuant and/or traceable to the IPO and suffered significant losses may consider filing a motion to serve as lead plaintiff. The role enables investors to direct litigation strategy and help ensure the case is pursued in the best interests of the class. You do not need to serve as lead plaintiff to share in any recovery. About Cohen Milstein With over 100 attorneys in eight offices, Cohen Milstein is one of the nation’s leading plaintiffs’ law firms. The firm has recovered billions of dollars for investors, including a $1 billion settlement in In re Wells Fargo Securities Litigation, and is routinely ranked and recognized by industry trade publications like The Legal 500, Chambers USA, and Law360 for its excellence in securities litigation. CONTACT: Molly Bowen, Esq. Licensed in DC, Florida, and Ohio Cohen Milstein Sellers & Toll PLLC 1100 New York Avenue, N.W., Eighth Floor Washington, D.C. 20005 Phone: (888) 240-0775 or (202) 408-4600 Email: [email protected] Website: www.cohenmilstein.com Attorney Advertising. Prior results do not guarantee a similar outcomes.
Reminder from Cohen Milstein: Zenas BioPharma (ZBIO) Lead Plaintiff Deadline in ZBIO Stock Drop Suit Approaching
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...